Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-21-016976

Options or other derivatives

  • Executive Vice President acquired 376,449 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BOYER ANDREW S Executive Vice President 2021-03-01 Grant or award · Restricted Stock Units +125,483 125,483 D: show line 1 in the form
BOYER ANDREW S Executive Vice President 2021-03-01 Grant or award · Performance-Based Restricted Stock Units +250,966 250,966 D: show line 2 in the form
Loading xslF345X03/doc4.xml…